17.59
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
12.95%
220.50
|
195.21 | 224.93 | 234.21 | 568.44 |
| Nonoperating Income/Loss |
17.14%
4.796
|
5.788 | 5.753 | 2.418 | 2.729 |
| Net Income/Loss |
13.87%
-215.70
|
-189.42 | -219.17 | -231.79 | -565.71 |
| Basic Average Shares |
0.35%
778.18
|
775.46 | 6.3137 | 743.42 | 742.62 |
| Diluted Average Shares |
0.35%
778.18
|
775.46 | 6.3137 | 743.42 | 742.62 |
| Basic Earnings Per Share |
16.67%
-0.28
|
-0.24 | -0.28 | -0.31 | -0.76 |
| Diluted Earnings Per Share |
16.67%
-0.28
|
-0.24 | -0.28 | -0.31 | -0.76 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):